简体中文 ENGLISH
Unistan Pharma Industrial Group
News

NEWS

Home>News

News

UNISTAN was awarded the title of "AAA Enterprise of Market Quality Credit Rating Evaluation"

On April 29, 2022, Shandong Quality Association awarded our company the medal and certificate of "AAA Enterprise of Market Quality Credit Rating Evaluation". The market quality credit rating evaluation is a reflection of an enterprise's law-abiding behavior and social responsibility ability, and it is also an authoritative expression of an enterprise's operational quality management status. It not only becomes an important reference for decision-making between enterprises and customers, shareholders, suppliers and other related parties, but also provides enterprises with preferential credit support from financial institutions, opens up more financing, provides special loans with preferential interest rates, and obtains funds for government policy projects. and other aspects of the "green channel". It is the "identity card" of market quality and credit value, and it is also a valuable intangible asset for enterprises to enhance their brand value and brand competitiveness.

For a long time, UNISTAN has always adhered to and practiced the corporate mission of "everything is for the health of the people" and the corporate vision of "revitalizing the vanguard of traditional Chinese medicine". Recognized and praised by consumers, it has won many honors in the industry.

The acquisition of this honor indicates that the quality of UNISTAN's operation has been further recognized and affirmed by the market, which will help to continuously improve our credit construction level in the field of quality and the ability to satisfy customers, and provide strong support for our sustainable development.

Deutsch Francies Japanese Spanish Arabia Russian